With the aspiration to reveal the mechanism by which PGM5‐AS1 affects EMT, invasion, and migration of osteosarcoma cells, we used shRNA to alter the level of PGM5‐AS1 in U2OS and HOS cells. Here, PGM5 is linked to osteosarcoma.